Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Ependymoma × Doxorubicin × Clear all

Sponsor

Conditions

Breast Neoplasms 103 Lymphoma 67 Lymphoma, Large B-Cell, Diffuse 48 Precursor Cell Lymphoblastic Leukemia-Lymphoma 41 Sarcoma 33 Lymphoma, Non-Hodgkin 29 Hodgkin Disease 27 Leukemia 23 Burkitt Lymphoma 22 Neoplasms 19 Lymphoma, Mantle-Cell 18 Triple Negative Breast Neoplasms 15 Multiple Myeloma 15 Lymphoma, Follicular 15 Lymphoma, B-Cell 14 Lymphoma, Large-Cell, Anaplastic 12 Carcinoma, Hepatocellular 12 Breast Neoplasms, Male 11 Neuroblastoma 10 Recurrence 9 Ovarian Neoplasms 9 Neoplasm Metastasis 9 Inflammatory Breast Neoplasms 9 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 8 Lymphoma, T-Cell, Peripheral 8 Lymphoma, T-Cell 8 Osteosarcoma 7 Fallopian Tube Neoplasms 7 Urinary Bladder Neoplasms 6 Liposarcoma 6

Interventions

Temozolomide 7 Magnetic Resonance Spectroscopy 7 X-Rays 5 Phantoms, Imaging 5 Bevacizumab 5 Specimen Handling 4 Nuclear Medicine Department, Hospital 4 Carboplatin 3 Biopsy 3 ulixertinib 2 tipifarnib 2 tazemetostat 2 selpercatinib 2 palbociclib 2 olaparib 2 larotrectinib 2 ivosidenib 2 erdafitinib 2 Vemurafenib 2 Lapatinib 2 LY3023414 2 Everolimus 2 Etoposide 2 Erlotinib Hydrochloride 2 veliparib 1 pomalidomide 1 poly ICLC 1 picropodophyllin 1 marizomib 1 imetelstat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡